Recombinant DNA Technology 2018 Global Market Key Players – Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript – Analysis and Forecast to 2025

This report focuses on the global Recombinant DNA Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant DNA Technology development in United States, Europe and China.

In 2017, the global Recombinant DNA Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study 
Monsanto Company 
Roche 
Biogen 
Amgen 
Novartis 
Eli Lilly and Company 
GenScript 
Pfizer Inc. 
Novo Nordisk 
Sanofi 
Merck KGaA 
Profacgen 
Biocon 
GlaxoSmithKline 
Cibus 
Horizon Discovery Group 
New England Biolabs

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3357730-global-recombinant-dna-technology-market-size-status-and-forecast-2018-2025                                        

Market segment by Type, the product can be split into 
Therapeutic Agent 
Vaccine 
Biotech Crops 
Specialty Chemicals

Market segment by Application, split into 
Biotechnology and Pharmaceutical Companies 
Academic & Government Research Institutes 
Others

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

Complete Report Details @ https://www.wiseguyreports.com/reports/3357730-global-recombinant-dna-technology-market-size-status-and-forecast-2018-2025                                 

Table Of Contents:      

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Recombinant DNA Technology Market Size Growth Rate by Type (2013-2025) 
1.4.2 Therapeutic Agent 
1.4.3 Vaccine 
1.4.4 Biotech Crops 
1.4.5 Specialty Chemicals 
1.5 Market by Application 
1.5.1 Global Recombinant DNA Technology Market Share by Application (2013-2025) 
1.5.2 Biotechnology and Pharmaceutical Companies 
1.5.3 Academic & Government Research Institutes 
1.5.4 Others 
1.6 Study Objectives 
1.7 Years Considered

2 Global Growth Trends 
2.1 Recombinant DNA Technology Market Size 
2.2 Recombinant DNA Technology Growth Trends by Regions 
2.2.1 Recombinant DNA Technology Market Size by Regions (2013-2025) 
2.2.2 Recombinant DNA Technology Market Share by Regions (2013-2018) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities

…..

12 International Players Profiles 
12.1 Monsanto Company 
12.1.1 Monsanto Company Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Recombinant DNA Technology Introduction 
12.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2013-2018) 
12.1.5 Monsanto Company Recent Development 
12.2 Roche 
12.2.1 Roche Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Recombinant DNA Technology Introduction 
12.2.4 Roche Revenue in Recombinant DNA Technology Business (2013-2018) 
12.2.5 Roche Recent Development 
12.3 Biogen 
12.3.1 Biogen Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Recombinant DNA Technology Introduction 
12.3.4 Biogen Revenue in Recombinant DNA Technology Business (2013-2018) 
12.3.5 Biogen Recent Development 
12.4 Amgen 
12.4.1 Amgen Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Recombinant DNA Technology Introduction 
12.4.4 Amgen Revenue in Recombinant DNA Technology Business (2013-2018) 
12.4.5 Amgen Recent Development 
12.5 Novartis 
12.5.1 Novartis Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Recombinant DNA Technology Introduction 
12.5.4 Novartis Revenue in Recombinant DNA Technology Business (2013-2018) 
12.5.5 Novartis Recent Development 

 Continued…….                                                      

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)